Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool risk calculation engine
Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool risk calculation engine
Aims/hypothesis: individualised variable-interval risk-based screening offers better targeting and improved cost-effectiveness in screening for diabetic retinopathy. We developed a generalisable risk calculation engine (RCE) to assign personalised intervals linked to local population characteristics, and explored differences in assignment compared with current practice.
Methods: data from 5 years of photographic screening and primary care for people with diabetes, screen negative at the first of > 1 episode, were combined in a purpose-built near-real-time warehouse. Covariates were selected from a dataset created using mixed qualitative/quantitative methods. Markov modelling predicted progression to screen-positive (referable diabetic retinopathy) against the local cohort history. Retinopathy grade informed baseline risk and multiple imputation dealt with missing data. Acceptable intervals (6, 12, 24 months) and risk threshold (2.5%) were established with patients and professional end users.
Results: data were from 11,806 people with diabetes (46,525 episodes, 388 screen-positive). Covariates with sufficient predictive value were: duration of known disease, HbA1c, age, systolic BP and total cholesterol. Corrected AUC (95% CIs) were: 6 months 0.88 (0.83, 0.93), 12 months 0.90 (0.87, 0.93) and 24 months 0.91 (0.87, 0.94). Sensitivities/specificities for a 2.5% risk were: 6 months 0.61, 0.93, 12 months 0.67, 0.90 and 24 months 0.82, 0.81. Implementing individualised RCE-based intervals would reduce the proportion of people becoming screen-positive before the allocated screening date by > 50% and the number of episodes by 30%.
Conclusions/interpretation: the Liverpool RCE shows sufficient performance for a local introduction into practice before wider implementation, subject to external validation. This approach offers potential enhancements of screening in improved local applicability, targeting and cost-effectiveness.
Diabetic retinopathy, Risk calculation engine, Risk-based screening
2174-2182
Eleuteri, Antonio
751fdb42-d0c0-49a8-80c3-d55e2b3cae60
Fisher, Anthony C.
549d479f-c5c5-4f96-add1-afccc07ee098
Broadbent, Deborah M.
b8be8c08-fcc5-430b-a15b-892dca6755b3
García-Fiñana, Marta
3ed2efab-455f-42bf-ae3e-4171a6af98ed
Cheyne, Christopher P.
ec078d25-27f4-4e9f-a8ed-0066d33a492c
Wang, Amu
aedb6067-d86c-4f26-bba1-d8a8911a995a
Stratton, Irene M.
772f25b9-23c0-4240-a3f6-1e76b03b172f
Gabbay, Mark
8a2b4866-65d4-4690-aeba-6545d2895e6f
Seddon, Daniel
704b646b-e992-4434-abab-49505d551e33
Harding, Simon P.
10091207-4f52-491b-b069-98bb37444f5b
for the Individualised Screening for Diabetic Retinopathy (ISDR) Study Group
Eleuteri, Antonio
751fdb42-d0c0-49a8-80c3-d55e2b3cae60
Fisher, Anthony C.
549d479f-c5c5-4f96-add1-afccc07ee098
Broadbent, Deborah M.
b8be8c08-fcc5-430b-a15b-892dca6755b3
García-Fiñana, Marta
3ed2efab-455f-42bf-ae3e-4171a6af98ed
Cheyne, Christopher P.
ec078d25-27f4-4e9f-a8ed-0066d33a492c
Wang, Amu
aedb6067-d86c-4f26-bba1-d8a8911a995a
Stratton, Irene M.
772f25b9-23c0-4240-a3f6-1e76b03b172f
Gabbay, Mark
8a2b4866-65d4-4690-aeba-6545d2895e6f
Seddon, Daniel
704b646b-e992-4434-abab-49505d551e33
Harding, Simon P.
10091207-4f52-491b-b069-98bb37444f5b
for the Individualised Screening for Diabetic Retinopathy (ISDR) Study Group
(2017)
Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool risk calculation engine.
Diabetologia, 60 (11), .
(doi:10.1007/s00125-017-4386-0).
Abstract
Aims/hypothesis: individualised variable-interval risk-based screening offers better targeting and improved cost-effectiveness in screening for diabetic retinopathy. We developed a generalisable risk calculation engine (RCE) to assign personalised intervals linked to local population characteristics, and explored differences in assignment compared with current practice.
Methods: data from 5 years of photographic screening and primary care for people with diabetes, screen negative at the first of > 1 episode, were combined in a purpose-built near-real-time warehouse. Covariates were selected from a dataset created using mixed qualitative/quantitative methods. Markov modelling predicted progression to screen-positive (referable diabetic retinopathy) against the local cohort history. Retinopathy grade informed baseline risk and multiple imputation dealt with missing data. Acceptable intervals (6, 12, 24 months) and risk threshold (2.5%) were established with patients and professional end users.
Results: data were from 11,806 people with diabetes (46,525 episodes, 388 screen-positive). Covariates with sufficient predictive value were: duration of known disease, HbA1c, age, systolic BP and total cholesterol. Corrected AUC (95% CIs) were: 6 months 0.88 (0.83, 0.93), 12 months 0.90 (0.87, 0.93) and 24 months 0.91 (0.87, 0.94). Sensitivities/specificities for a 2.5% risk were: 6 months 0.61, 0.93, 12 months 0.67, 0.90 and 24 months 0.82, 0.81. Implementing individualised RCE-based intervals would reduce the proportion of people becoming screen-positive before the allocated screening date by > 50% and the number of episodes by 30%.
Conclusions/interpretation: the Liverpool RCE shows sufficient performance for a local introduction into practice before wider implementation, subject to external validation. This approach offers potential enhancements of screening in improved local applicability, targeting and cost-effectiveness.
Text
s00125-017-4386-0
- Version of Record
More information
Accepted/In Press date: 12 June 2017
e-pub ahead of print date: 24 August 2017
Additional Information:
Funding Information:
Funding This manuscript presents independent research funded by the National Institute for Health Research (NIHR; RP-PG-1210-12016). The views expressed are those of the authors, not those of the UK National Health Service, NIHR or Department of Health. MGF is part funded by NIHR Collaboration for Leadership in Applied Health Research and Care North West Coast (NIHR CLAHRC NWC).
Keywords:
Diabetic retinopathy, Risk calculation engine, Risk-based screening
Identifiers
Local EPrints ID: 486984
URI: http://eprints.soton.ac.uk/id/eprint/486984
ISSN: 0012-186X
PURE UUID: 5c668974-1f7a-44b5-956a-bfeb480bfe97
Catalogue record
Date deposited: 09 Feb 2024 17:32
Last modified: 18 Mar 2024 04:01
Export record
Altmetrics
Contributors
Author:
Antonio Eleuteri
Author:
Anthony C. Fisher
Author:
Deborah M. Broadbent
Author:
Marta García-Fiñana
Author:
Christopher P. Cheyne
Author:
Amu Wang
Author:
Irene M. Stratton
Author:
Mark Gabbay
Author:
Daniel Seddon
Author:
Simon P. Harding
Corporate Author: for the Individualised Screening for Diabetic Retinopathy (ISDR) Study Group
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics